Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
Environmental Pollution (Barking, Essex : 1987)|March 9, 2020
Long-term exposure to outdoor and household air pollution and blood pressure in the Prospective Urban and Rural Epidemiological (PURE) studyRaphael E Arku, Michael Brauer, Suad H Ahmed, et al.
The Lancet. Global Health|September 30, 2024
Assessing the built environment through photographs and its association with obesity in 21 countries: the PURE StudyDaniel J Corsi, Simone Marschner, Scott Lear, et al.
Neuroepidemiology|May 5, 2021
Renal Impairment and Risk of Acute Stroke: The INTERSTROKE StudyAndrew Smyth, Conor Judge, Xingu Wang, et al.
Circulation|April 28, 2021
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 CountriesIsabelle Johansson, Philip Joseph, Kumar Balasubramanian, et al.
The Lancet. Diabetes & Endocrinology|January 12, 2020
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trialHertzel C Gerstein, Robert Hart, Helen M Colhoun, et al.
Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trialStuart J Connolly, John W Eikelboom, Jackie Bosch, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
The New England Journal of Medicine|February 12, 2011
Apixaban in patients with atrial fibrillationStuart J Connolly, John Eikelboom, Campbell Joyner, et al.
JAMA Internal Medicine|March 8, 2021
Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 CountriesDeepa Mohan, Andrew Mente, Mahshid Dehghan, et al.
Archivos De Cardiologia De Mexico|June 29, 2021
Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)Carlos I Ponte-Negretti, Fernando S Wyss, Daniel Piskorz, et al.
Pageof 24